Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.99228 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.9353 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.84722 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.24432 | 94 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.95238 | 93 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.75258 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.63397 | 93 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.87581 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.66146 | 92 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.76051 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.75199 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.78704 | 92 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.74793 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.71921 | 92 |